Q1 FY27 call: revenue up 21%, EBITDA margin expands to 17.9%
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ind-Swift Labs Q1 FY27 revenue grew 21% YoY to Rs 186.08 cr. Operating EBITDA jumped 2.85x to Rs 33.32 cr with margin expanding 1258 bps to 17.91%. PAT (ex-exceptional) rose 2.04x to Rs 24.68 cr. CDMO tie-ups with Viatris, Manx UK, and Arrotex Australia commercialized, expected to add Rs 200-220 cr in FY27. Export share rose to 57.2% of sales from 48%. Management guides 18% sustainable EBITDA margin, possibly 21-22%, Rs 900 cr FY27 revenue, Rs 1,200 cr by FY29, and Rs 1,500 cr revenue with Rs 200 cr plus PAT by FY30. Capex of Rs 250 cr planned over 2.5 years.
Strong margin expansion and CDMO ramp-up signal improving earnings quality; multiyear revenue targets point to sustained growth ahead.